Cardiovascular risk assessment according to a national calibrated score risk index in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

Joint Bone Spine

Volumn 81, Issue 2, 2014, Pages 164-168

  Rosales Alexander, José Luis ^a   Cantero Hinojosa, Jesús ^a   Salvatierra, Juan ^a   Magro Checa, César ^a   González Gay, Miguel Ángel ^b   Raya Álvarez, Enrique ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Cardiovascular events; Cardiovascular risk; EULAR task force recommendations; Psoriatic arthritis; SCORE

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PROTEIN BLOOD LEVEL; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SYSTEMATIC CORONARY RISK EVALUATION INDEX; TRIACYLGLYCEROL BLOOD LEVEL; ASSESSMENT OF HUMANS; HIGH RISK POPULATION; INTERMEDIATE RISK POPULATION; LOW RISK POPULATION; SCORING SYSTEM;

CARDIOVASCULAR EVENTS; CARDIOVASCULAR RISK; EULAR TASK FORCE RECOMMENDATIONS; PSORIATIC ARTHRITIS; SCORE;

ADULT; ARTHRITIS, PSORIATIC; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 84898538236     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.07.008     Document Type: Article

References (22)

1. Wonk K., Gladman D.D., Husted J., et al. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997, 40:1868-1872.
2. Gladdman D.D., Farewell V.T., Wong K., et al. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. II. Prognostic indicators for death. Arthritis Rheum 1998, 41:1103-1110.
3. Shbeeb M., Uramoto K.M., Gibson L.E., et al. The epidemiology of psoriatic arthritis in Olmstead County, Minnesota, USA, 1982-1991. J Rheumatol 2000, 27:1247-1250.
4. Prati C., Claudepierre P., Pham T., et al. Mortality in spondylarthritis. Joint Bone Spine 2011, 78:466-470.
5. Han C., Robinson D.W., Hackett M.V., et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosin spondylitis. J Rheumatol 2006, 33:2167-2172.
6. Mathieu S., Motreff P., Soubrier M. Spondyloarthropathies: an independent cardiovascular risk factor?. Joint Bone Spine 2010, 77:542-545.
7. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-993.
8. Graham I., Atar D., Borch-Johnsen K., et al. Fourth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (European guidelines on cardiovascular disease prevention in clinical practice: executive summary). Eur J Cardiovasc Prev Rehabil 2007, 14:S1-S40.
9. Peters M.J., Symmons D.P., McCarey D., et al. EULAR evidenced-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010, 69:325-331.
10. Sans S., Fitzgerald A.P., Royo D., et al. Calibración de la tabla SCORE del riesgo cardiovascular para España. Rev Esp Cardiol 2007, 60:476-485.
11. Zhu T., Li E.K., Tam L.S. Cardiovascular risk in patients with psoriatic arthritis. Int J Rheumatol 2012, 2012:714321. 10.1155/2012/714321.
12. Jamnitski A., Symmons D., Peters M.J.L., et al. Extended report: cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 2013, 72:211-216.
13. Husted J.A., Thavaneswaran A., Chandran V., et al. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care Res 2011, 63:1729-1735.
14. Gonzalez-Juanatey C., Llorca J., Amigo-Diaz E., et al. High prevalence of subclinical aterosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic aterosclerosis risk factors. Arthritis Care Res 2007, 55:1074-1080.
15. Pereira I.A., Ferreira E. The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis. Swiss Med Wkly 2008, 138:534-539.
16. Tam L.S., Shang Q., Li E.K., et al. Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 2008, 59:1322-1331.
17. Crowson C.S., Gabriel S.E. Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 2011, 70:719-721.
18. Lorenz M.W., von Kegler S., Steinmetz H., et al. M.Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006, 37:87-92.
19. Greenland P., Alpert J.S., Beller G.A., et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010, 122:2748-2764.
20. González-Gay M.A., González-Juanatey C., Llorca J. Carotid ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis: when and for whom?. Ann Rheum Dis 2012, 71:796-798.
21. Gonzalez-Juanatey C., Llorca J., Testa A., et al. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 2003, 82:407-413.
22. Gonzalez-Gay M.A., Gonzalez-Juanatey C., Piñeiro A., et al. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005, 32:1219-1223.